PowerHeart

PowerHeart®

Cardiology An AECD designed to monitor cardiac rhythm and to automatically defibrillate when life-threatening arrhthymias are detected. See Automatic external cardioverter-defibrillator.
References in periodicals archive ?
In the study, the Powerheart device was attached to 117 at-risk patients--most with coronary artery disease and some with persistent atrial fibrillation.
Cardiac Science also announced it entered into an exclusive distribution agreement for Australia and sold 50 of its Powerheart defibrillator-monitors along with disposable defibrillation electrodes and related accessories resulting in $333,500 in revenue.
This sales increase represents growing demand for the Powerheart technology," said Michael Gioffredi, vice president, sales and marketing.
Department of Energy (DOE) Office of Science, purchased the Powerheart G5s to upgrade the laboratory's existing AED program.
The issuance of the patent preludes the first quarter 2004 launch of Cardiac Science's fully-automatic version of its Powerheart AED G3.
has been granted approval by the Australian Therapeutic Goods Administration to allow Cardiac Science to begin marketing its unique fully automatic Powerheart hospital bedside defibrillator-monitor in Australia.
In controlled multi-center clinical studies, the Powerheart demonstrated a response time of 21 seconds from onset to first defibrillation.
Additionally, the patented RescueReady(R) technology used in the Powerheart line of AEDs is capable of self-testing the defibrillator on a daily, weekly, and monthly basis so that potential rescuers will know for certain that the device is capable of performing at all times.
This is why Cardiac Science, a global leader in AEDs, is proud to announce that the Lafayette County Sheriff's Office selected Powerheart G5 AEDs to help their patrol officers save lives.
Cardiac Science develops, manufactures and markets Powerheart-brand automated portable public access defibrillators, Diascope-brand patient monitors and Powerheart CRM, the only FDA-cleared therapeutic patient monitor that instantly and automatically treats hospitalized cardiac patients who suffer life-threatening heart rhythms.
The proceeds from this financing will be employed to drive adoption for our initial commercial product, the Powerheart, and to develop additional embodiments of our life-saving fully automatic defibrillation technology.
15, 2015 /PRNewswire/ -- Cardiac Science, a global leader in automated external defibrillators (AEDs), announced today that the company has amended its existing AED contract with the state of New Jersey to now include the new Powerheart G5 AED--the first FDA-cleared AED to offer a combination of automatic shock delivery, variable escalating energy, and rapid shock times.